Specialty Pharma Journal Specialty, Precision & Technology
ANN ARBOR, Michigan — In the hunt for novel treatments against an aggressive form of breast cancer, researchers combined a new protein inhibitor with a chemotherapy drug to create a powerful combination that resulted in cancer cell death. Triple-negative breast cancer is a subtype that does not express hormone receptor …
Tag Archives: University of Michigan
September, 2017
-
22 September
‘Labyrinth’ Chip Could Help Monitor Aggressive Cancer Stem Cells
ANN ARBOR–Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. It is already in use in a breast cancer clinical trial. Tumor cells isolated …
May, 2017
-
24 May
Largest Psoriasis Meta-Analysis to Date Yields New Genetic Clues
It’s one of the most common immune-mediated diseases in the U.S., causing red, patchy and scaly marks on the skin. Yet the 1 to 2 percent of the population who have psoriasis are still left to wonder why. A new study builds on the genetic architecture of psoriasis, the next …
December, 2016
-
16 December
Investigating Kidney Biomarkers to Track Lupus
ANN ARBOR, Mich. – Lupus, a chronic autoimmune disease, can wreak havoc on an affected individual’s body through inflammation, pain and even damage of the skin, joints and organs. To try to better understand how the disease begins and progresses, researchers at the University of Michigan investigated whether kidney biomarkers …
April, 2015
-
1 April
Researchers Develop New Drug Candidate that Shows Potential in Treating Rare Leukemia
University of Michigan Comprehensive Cancer Center researchers have developed a new potential drug candidate that shows promise against a rare type of blood cancer, as well as potential in prostate cancer. The new drug candidate showed potential in laboratory studies against a rare type of acute leukemia. Additionally, separate studies …